Cargando…
In vivo CART cell imaging: Paving the way for success in CART cell therapy
Chimeric antigen receptor T (CART) cells are a promising immunotherapy that has induced dramatic anti-tumor responses in certain B cell malignancies. However, CART cell expansion and trafficking are often insufficient to yield long-term remissions, and serious toxicities can arise after CART cell ad...
Autores principales: | Sakemura, Reona, Can, Ismail, Siegler, Elizabeth L., Kenderian, Saad S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7995489/ https://www.ncbi.nlm.nih.gov/pubmed/33816781 http://dx.doi.org/10.1016/j.omto.2021.03.003 |
Ejemplares similares
-
GM-CSF disruption in CART cells modulates T cell activation and enhances CART cell anti-tumor activity
por: Cox, Michelle J., et al.
Publicado: (2022) -
CART Cell Toxicities: New Insight into Mechanisms and Management
por: Zahid, Anas, et al.
Publicado: (2020) -
CAR T cell therapy and the tumor microenvironment: Current challenges and opportunities
por: Kankeu Fonkoua, Lionel A., et al.
Publicado: (2022) -
P1359: TUMOR-SPECIFIC, T-CELL-TARGETING MICRORNA IS ASSOCIATED WITH CART CELL FAILURE IN B CELL MALIGNANCIES
por: Chohan, Karan, et al.
Publicado: (2023) -
Characterization of the Two CART Genes (CART1 and CART2) in Chickens (Gallus gallus)
por: Cai, Guoqing, et al.
Publicado: (2015)